The defining pathological hallmark of Alzheimer's disease (AD) is the accumulation of amyloid β protein (Aβ) in brain associated with tau pathology, synapse loss, cytoskeletal aberrations, mitochondrial dysfunction, and cognitive decline. Here, MAPT is linked to Alzheimer disease.